PHARPharming Group N.V.
What is the market doing?
No clear lean: rangebound and a token position.
Rangebound, no clear trend. Price is −23% vs its 200-day average.
A token position, settled Sep 30, 2026, a few days of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PHAR is trading
Pharming Group N.V. is −25% over the past year while the S&P 500 is +16%: 41 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −23%
vs 200-day average · a clear downtrend
- RSI (14)
- 66
RSI (14) · neutral
- Below its 52-week high
- 48%
Below its 52-week high
Details›
- Last close2026-10-23
- $11.07
- 1 monthS&P 500 −0.94%
- +4.4%
- 1 yearS&P 500 +16%
- −25%
- 5 yearsS&P 500 +86%
- +14%
- vs 50-day average$10.89
- +1.7%
- 52-week high
- $21.18
- 52-week low
- $9.30
- Annualised volatility
- 66%
| Year | Return |
|---|---|
| 2026 (year to date) | −37% |
| 2025 | +76% |
| 2024 | −12% |
| 2023 | +3.6% |
| 2022 | +23% |
| 2021 | −41% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 4 of 6 | +5.0% |
| Feb | 6 | 1 of 6 | −6.9% |
| Mar | 6 | 2 of 6 | −0.86% |
| Apr | 6 | 2 of 6 | −5.1% |
| May | 6 | 2 of 6 | −1.1% |
| Jun | 6 | 3 of 6 | −0.90% |
| Jul | 6 | 3 of 6 | −5.6% |
| Aug | 6 | 4 of 6 | +17% |
| Sep | 6 | 1 of 6 | −8.3% |
| Oct | 6 | 3 of 6 | +0.85% |
| Nov | 5 | 2 of 5 | +6.3% |
| Dec | 5 | 3 of 5 | +7.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.